Begin your type 2 diabetes management journey effectively with SEMA-Q 0.25 mg (1’s), an affordable generic semaglutide. This once-weekly injectable GLP-1 receptor agonist mimics the body’s natural GLP-1 hormone to stimulate insulin release when blood sugar rises, suppress glucagon, slow gastric emptying, and increase feelings of fullness — helping achieve better glycemic control, potential weight loss, and lowered risk of major cardiovascular events (such as heart attack or stroke) in patients with type 2 diabetes and established heart disease. The 0.25 mg strength serves as the recommended initiation dose for the first 4 weeks to allow your body to adjust and minimize common gastrointestinal side effects like nausea. After 4 weeks (under medical supervision), the dose is typically increased to 0.5 mg weekly for ongoing therapeutic benefits. Administer subcutaneously in the abdomen, thigh, or upper arm on the same day each week, with or without food. It works best when combined with a healthy diet, regular physical activity, and other diabetes treatments like metformin. This pre-filled pen or single-dose injection requires a prescription. Always consult your doctor for personalized dosing, monitoring (blood sugar, thyroid, kidney function), and to discuss potential side effects (nausea, vomiting, diarrhea, or rare serious risks like pancreatitis or thyroid issues). Not intended for type 1 diabetes, diabetic ketoacidosis, or as a standalone weight-loss treatment without medical oversight. Rely on SEMA-Q for reliable, cost-effective semaglutide therapy to support long-term blood sugar stability and health in Kenya.
